HMGB1 and cancer: The HMGB1 released by ferroptotic cancer cells activated innate immune cells and triggered an inflammatory response that was dependent on HMGB1 binding to the cognate receptor, advanced glycosylation end product-specific receptor (AGER), and not toll-like receptor 4 (TLR4) on macrophages (Fig. 4A).